| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
SAN DIEGO—Data pipeline and workflow tools company SciTegic and Tripos Inc. announced in late June that Tripos joined SciTegic's independent software vendor (ISV) partner program to provide software compatibility between their product lines. Joint customers may now choose to access Tripos' discovery informatics technology from within SciTegic's Pipeline Pilot framework, leading to more efficient and repeatable discovery processes.
 
"Many of our customers already use Tripos' software and find it to be critical to their discovery research processes," says Mathew Hahn, Ph.D., vice president and general manager of SciTegic. "Through this partnership, our joint users will employ Tripos technologies in the workflow-centric Pipeline Pilot environment to solve more complex problems, and to reach a broader audience of users through the flexible deployment of validated processing routines."
 
"It makes sense for us to partner with SciTegic because the strength of Pipeline Pilot is the ease with which a users can establish a link to an existing third-party Web service, which we now have," says Davin Potts, product manager for operational informatics and platform technologies with Tripos. "This really gives a lot more effective functionality from our tools for our customers."

About the Author

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue